A randomized clinical trial of an interactive voice response and text message intervention for individuals with hypertension
- PMID: 32516486
- PMCID: PMC8029814
- DOI: 10.1111/jch.13909
A randomized clinical trial of an interactive voice response and text message intervention for individuals with hypertension
Abstract
Interactive voice response and text message (IVR-T) technology may improve hypertension control in under-resourced settings. We conducted a randomized clinical trial to determine whether an IVR-T intervention would improve blood pressure (BP), medication adherence and visit keeping among adults with hypertension from multiple racial and ethnic groups in primary care at an Urban Indian Health Organization in Albuquerque, New Mexico. Two hundred and ninety-five participants were randomly assigned to IVR-T (N = 148) or to usual care (N = 147). The IVR-T arm received reminders for clinic visits, messages to reschedule missed clinic visits, monthly medication refill reminders, weekly motivational messages, and a blood pressure cuff. The usual care arm received no messages. The primary outcome was change in systolic BP (SBP) between baseline and 12 months. Secondary outcomes included change in SBP between baseline and 6 months, change in diastolic BP (DBP) at 6 and 12 months, self-reported adherence at 6 months, and the proportion of missed primary care clinic appointments. The intervention did not affect SBP or DBP at 6 or 12 months. The 12-month change in SBP/DBP was 1.66/1.10 mm Hg in usual care and 0.23/1.34 mm Hg in the intervention group (P values = .57 and .88, respectively). Self-reported medication adherence improved comparably in both groups, and there was no difference in percentage of kept visits. Several features of study design, clinic operations, and data transfer were barriers to demonstrating effectiveness.
Trial registration: ClinicalTrials.gov NCT03135405.
Keywords: American Indians; disparities; hypertension; medication adherence; primary care visits; randomized trial.
© 2020 Wiley Periodicals LLC.
Conflict of interest statement
All authors disclose financial support from the American Heart Association and some authors also disclose support from the National Institute for Diabetes and Digestive and Kidney Diseases. EBS and JFS had full access to all the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis.
Figures
References
-
- Chow CK, Redfern J, Hillis GS, et al. Effect of lifestyle‐focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA. 2015;314:1255‐1263. - PubMed
-
- Thakkar J, Kurup R, Laba TL, et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta‐analysis. JAMA Intern Med. 2016;176:340‐349. - PubMed
-
- Gwadry‐Sridhar FH, Manias E, Lal L, et al. Impact of interventions on medication adherence and blood pressure control in patients with essential hypertension: a systematic review by the ISPOR medication adherence and persistence special interest group. Value Health. 2013;16:863‐871. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
